申请人:——
公开号:US20010029035A1
公开(公告)日:2001-10-11
The present invention relates to an oligonucleotide conjugate, comprising: (a) an oligonucleotide at least part of whose sequence is complementary to an intracellular nucleic acid sequence; and (b) a somatostatin analog. The present invention also relates to a medicament containing this oligonucleotide conjugate, preferably for treating tumors in which the somatostatin receptor (SSTR) is overexpressed.
本发明涉及一种寡核苷酸共轭物,包括:(a)至少部分序列与细胞内核酸序列互补的寡核苷酸;和(b)生长抑素类似物。本发明还涉及一种含有该寡核苷酸共轭物的药物,优选用于治疗生长抑素受体(SSTR)过度表达的肿瘤。